<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24411/2587-7836-2018-10004.</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-50</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ФАРМАКОДИНАМИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL PHARMACODYNAMICS STUDIES</subject></subj-group></article-categories><title-group><article-title>Изучение ангиотропной активности фактора роста нервов в опытах на культуре эндотелиальных клеток человека (HUVEC) Теравит Антистресс и его компонентов</article-title><trans-title-group xml:lang="en"><trans-title>Study of angiotropic activity of the nerve growth factor in experiments on human endothelial cell culture (HUVEC)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пекельдина</surname><given-names>Евгения Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Pekeldina</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаев</surname><given-names>Сергей Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Nicolaev</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антипова</surname><given-names>Татьяна Алексеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Antipova</surname><given-names>T. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крыжановский</surname><given-names>Сергей Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Kryzhanovskii</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">SAK-538@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт фармакологии имени В.В. Закусова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «Zakusov Institute of Pharmacology»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2018</year></pub-date><volume>0</volume><issue>1</issue><fpage>32</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пекельдина Е.С., Николаев С.В., Антипова Т.А., Крыжановский С.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Пекельдина Е.С., Николаев С.В., Антипова Т.А., Крыжановский С.А.</copyright-holder><copyright-holder xml:lang="en">Pekeldina E.S., Nicolaev S.V., Antipova T.A., Kryzhanovskii S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/50">https://www.pharmacokinetica.ru/jour/article/view/50</self-uri><abstract><p>В экспериментах in vitro, выполненных на культуре клеток эндотелия человека (HUVEC), изучали ангиотропные эффекты фактора роста нервов NGF. На интактной культуре клеток показано, что NGF в концентрации 10-9 M проявляет ангиогенные свойства и стимулирует начальную стадию ангиогенеза - тубулогенез, о чём свидетельствует статистически значимое по сравнению с контролем увеличение средней суммарной длины микротрубочек. В условиях оксидативного стресса NGF нивелирует повреждающее действие перекиси водорода в высокой концентрации (200 мкМ) и не только проявляет ангиопротекторное действие, но и препятствует развитию морфологических изменений ядерного хроматина, характерных для апоптоза. В этих условиях NGF (10-9 М) статистически значимо по сравнению с контролем снижает число клеток с конденсированным и фрагментированным хроматином: соответственно 44 ± 9 и 78 ± 9 (р ≤ 0,05). Полученные в работе результаты подтверждают данные о наличии у NGF ангиогенной активности и свидетельствуют о том, что в условиях повреждения эндотелиальных клеток сосудов оксидативным стрессом он проявляет выраженную ангиопротекторную и антиапоптотическую активность.</p></abstract><trans-abstract xml:lang="en"><p>Resume. In vitro experiments performed on human endothelial ceLL culture (HUVEC), nerve growth factor (NGF) angiotropic effects were studied. An intact ceLL culture it was shown that NGF exhibited angiogenic properties and stimulated the initial stage of angiogenesis -tubuLogenesis at a 10-9 M concentration, as evidenced by a statisticaLLy significant increase in the average totaL Length of microtubuLes compared with the control. Under conditions of oxidative stress, NGF neutraLizes the damaging effect of hydrogen peroxide in a high concentration (200 |±M) and not onLy shows an angioprotective effect, but aLso prevents the deveLopment of morphoLogicaL changes in nucLear chromatin, characteristic for apoptosis. Under these conditions NGF (10-9 M) reduces statisticaLLy significant by comparison with the controL the number of ceLLs with condensed and fragmented chromatin: 44 ± 9 and 78 ± 9 (р ≤ 0,05), respectiveLy. The obtained resuLts confirm the data about the NGF angiogenic activity and indicate that under conditions of the vesseLs endotheLiaL ceLLs damage by oxidative stress, it exhibits pronounced angioprotective and anti-apoptotic activity.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фактор роста нерва</kwd><kwd>клетки HUVEC</kwd><kwd>перекись водорода</kwd><kwd>оксидативный стресс</kwd><kwd>ангиопротекторная активность</kwd><kwd>антиапоптотическая</kwd><kwd>nerve growth factor</kwd><kwd>HUVEC ceLLs</kwd><kwd>hydrogen peroxide</kwd><kwd>oxidative stress</kwd><kwd>angioprotective activity</kwd><kwd>antiapoptotic activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001 Jan;2(1):24-32. DOI: 10.1038/35049004</mixed-citation><mixed-citation xml:lang="en">Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001 Jan;2(1):24-32. DOI: 10.1038/35049004</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bradshaw RA, Pundavela J, Biarc J, et al. NGF and proNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Adv Biol Regul. 2015 May;58:16-27. DOI: 10.1016/j.jbior.2014.11.003</mixed-citation><mixed-citation xml:lang="en">Bradshaw RA, Pundavela J, Biarc J, et al. NGF and proNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Adv Biol Regul. 2015 May;58:16-27. DOI: 10.1016/j.jbior.2014.11.003</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Schenck K, Schreurs O, Hayashi K, Helgeland K. The role of nerve growth factor (NGF) and its precursor forms in oral wound healing. Int J Mol Sci. 2017 Feb 11;18(2). pii: E386. DOI: 10.3390/ijms18020386</mixed-citation><mixed-citation xml:lang="en">Schenck K, Schreurs O, Hayashi K, Helgeland K. The role of nerve growth factor (NGF) and its precursor forms in oral wound healing. Int J Mol Sci. 2017 Feb 11;18(2). pii: E386. DOI: 10.3390/ijms18020386</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Saygili E, Kluttig R, Rana OR, et al. Age-related regional differences in cardiac nerve growth factor expression. Age (Dordr). 2012 Jun;34(3):659-667. DOI: 10.1007/s11357-011-9262-0</mixed-citation><mixed-citation xml:lang="en">Saygili E, Kluttig R, Rana OR, et al. Age-related regional differences in cardiac nerve growth factor expression. Age (Dordr). 2012 Jun;34(3):659-667. DOI: 10.1007/s11357-011-9262-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Retamales-Ortega R, Oröstica L, Vera C, et al. Role of nerve growth factor (NGF) and miRNAs in epithelial ovarian cancer. Int J Mol Sci. 2017 Feb 26;18(3). pii: E507. DOI: 10.3390/ijms18030507</mixed-citation><mixed-citation xml:lang="en">Retamales-Ortega R, Oröstica L, Vera C, et al. Role of nerve growth factor (NGF) and miRNAs in epithelial ovarian cancer. Int J Mol Sci. 2017 Feb 26;18(3). pii: E507. DOI: 10.3390/ijms18030507</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nico B, Mangieri D, Benagiano V, et al. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008 Mar;75(2):135- 141. DOI: 10.1016/j.mvr.2007.07.004</mixed-citation><mixed-citation xml:lang="en">Nico B, Mangieri D, Benagiano V, et al. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008 Mar;75(2):135- 141. DOI: 10.1016/j.mvr.2007.07.004</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ahluwalia A, Jones MK, Brzozowski T, Tarnawski AS. Nerve growth factor is critical requirement for in vitro angiogenesis in gastric endothelial cells. Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G981-G987. DOI: 10.1152/ajpgi.00334.2016</mixed-citation><mixed-citation xml:lang="en">Ahluwalia A, Jones MK, Brzozowski T, Tarnawski AS. Nerve growth factor is critical requirement for in vitro angiogenesis in gastric endothelial cells. Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G981-G987. DOI: 10.1152/ajpgi.00334.2016</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lazarovici P, Lahiani A, Gincberg G, et al. Nerve growth factor-induced angiogenesis: 1. Endothelial cell tube formation assay. Methods Mol Biol. 2018;1727:239-250. DOI: 10.1007/978-1-4939-7571-6_18</mixed-citation><mixed-citation xml:lang="en">Lazarovici P, Lahiani A, Gincberg G, et al. Nerve growth factor-induced angiogenesis: 1. Endothelial cell tube formation assay. Methods Mol Biol. 2018;1727:239-250. DOI: 10.1007/978-1-4939-7571-6_18</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mu P, Liu Q, Zheng R. Biphasic regulation of H2O2 on angiogenesis implicated NADPH oxidase. Cell Biol Int. 2010 Oct;34(10):1013- 1020. DOI: 10.1042/CBI20090092</mixed-citation><mixed-citation xml:lang="en">Mu P, Liu Q, Zheng R. Biphasic regulation of H2O2 on angiogenesis implicated NADPH oxidase. Cell Biol Int. 2010 Oct;34(10):1013- 1020. DOI: 10.1042/CBI20090092</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Diao YP, Cui FK, Yan S, et al. Nerve growth factor promotes angiogenesis and skeletal muscle fiber remodeling in a murine model of hindlimb ischemia. Chin Med J (Engl). 2016 Feb 5;129(3):313-319. DOI: 10.4103/0366-6999.174496</mixed-citation><mixed-citation xml:lang="en">Diao YP, Cui FK, Yan S, et al. Nerve growth factor promotes angiogenesis and skeletal muscle fiber remodeling in a murine model of hindlimb ischemia. Chin Med J (Engl). 2016 Feb 5;129(3):313-319. DOI: 10.4103/0366-6999.174496</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Fu X, Yu L, et al. Preconditioning with VEGF enhances angiogenic and neuroprotective effects of bone marrow mononuclear cell transplantation in a rat model of chronic cerebral hypoperfusion. Mol Neurobiol. 2016 Nov;53(9):6057- 6068. DOI: 10.1007/s12035-015-9512-8</mixed-citation><mixed-citation xml:lang="en">Wang J, Fu X, Yu L, et al. Preconditioning with VEGF enhances angiogenic and neuroprotective effects of bone marrow mononuclear cell transplantation in a rat model of chronic cerebral hypoperfusion. Mol Neurobiol. 2016 Nov;53(9):6057- 6068. DOI: 10.1007/s12035-015-9512-8</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Herkenne S, Paques C, Nivelles O, et al. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis. Sci Signal. 2015 Nov 17;8(403):ra117. DOI: 10.1126/scisignal.aaa2403</mixed-citation><mixed-citation xml:lang="en">Herkenne S, Paques C, Nivelles O, et al. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis. Sci Signal. 2015 Nov 17;8(403):ra117. DOI: 10.1126/scisignal.aaa2403</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Breuss JM, Uhrin P VEGF-initiated angiogenesis and the uPA/uPAR system. Cell Adh Migr. 2012 Nov-Dec;6(6):535-615. DOI: 10.4161/cam.22243</mixed-citation><mixed-citation xml:lang="en">Breuss JM, Uhrin P VEGF-initiated angiogenesis and the uPA/uPAR system. Cell Adh Migr. 2012 Nov-Dec;6(6):535-615. DOI: 10.4161/cam.22243</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Montuori N, Ragno P Role of uPA/uPAR in the modulation of angiogenesis. Chem Immunol Allergy. 2014;99:105- 122. DOI: 10.1159/000353310</mixed-citation><mixed-citation xml:lang="en">Montuori N, Ragno P Role of uPA/uPAR in the modulation of angiogenesis. Chem Immunol Allergy. 2014;99:105- 122. DOI: 10.1159/000353310</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ahluwalia A, Jones MK, Hoa N, Tarnawski AS. NGF protects endothelial cells from indomethacin-induced injury through activation of mitochondria and upregulation of IGF-1. Cell Signal. 2017 Dec;40:22-29. DOI: 10.1016/j.cellsig.2017.08.006</mixed-citation><mixed-citation xml:lang="en">Ahluwalia A, Jones MK, Hoa N, Tarnawski AS. NGF protects endothelial cells from indomethacin-induced injury through activation of mitochondria and upregulation of IGF-1. Cell Signal. 2017 Dec;40:22-29. DOI: 10.1016/j.cellsig.2017.08.006</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Urban D, Lorenz J, Meyborg H, et al. Proprotein convertase furin enhances survival and migration of vascular smooth muscle cells via processing of pro-nerve growth factor. J Biochem. 2013 Feb;153(2):197-207. DOI: 10.1093/jb/mvs137</mixed-citation><mixed-citation xml:lang="en">Urban D, Lorenz J, Meyborg H, et al. Proprotein convertase furin enhances survival and migration of vascular smooth muscle cells via processing of pro-nerve growth factor. J Biochem. 2013 Feb;153(2):197-207. DOI: 10.1093/jb/mvs137</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Han Y, Qi Y, Kang J, et al. Nerve growth factor promotes formation of lumen-like structures in vitro through inducing apoptosis in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2008 Feb 15;366(3):685- 691. DOI: 10.1016/j.bbrc.2007.11.160</mixed-citation><mixed-citation xml:lang="en">Han Y, Qi Y, Kang J, et al. Nerve growth factor promotes formation of lumen-like structures in vitro through inducing apoptosis in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2008 Feb 15;366(3):685- 691. DOI: 10.1016/j.bbrc.2007.11.160</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
